Gene Expression and Prognostic Value of NADPH Oxidase Enzymes in Breast Cancer
International Journal of Molecular Sciences · 19.03.2024 · 25 (6) · 3464
DOI: 10.3390/ijms25063464 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.03.2024. Verfasst von Andressa de Vasconcelos E Souza und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-971, Brazil. Hauptthemen laut MEDLINE: NADPH Oxidases, Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, National Council for Scientific and Technological Development.
Abstract (Originalsprache)
NADPH oxidase enzymes (NOX) are involved in all stages of carcinogenesis, but their expression levels and prognostic value in breast cancer (BC) remain unclear. Thus, we aimed to assess the expression and prognostic value of NOX enzymes in BC samples using online databases. For this, mRNA expression from 290 normal breast tissue samples and 1904 BC samples obtained from studies on cBioPortal, Kaplan–Meier Plotter, and The Human Protein Atlas were analyzed. We found higher levels of NOX2, NOX4, and Dual oxidase 1 (DUOX1) in normal breast tissue. NOX1, NOX2, and NOX4 exhibited higher expression in BC, except for the basal subtype, where NOX4 expression was lower. DUOX1 mRNA levels were lower in all BC subtypes. NOX2, NOX4, and NOX5 mRNA levels increased with tumor progression stages, while NOX1 and DUOX1 expression decreased in more advanced stages. Moreover, patients with low expression of NOX1, NOX4, and DUOX1 had lower survival rates than those with high expression of these enzymes. In conclusion, our data suggest an overexpression of NOX enzymes in breast cancer, with certain isoforms showing a positive correlation with tumor progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-971, Brazil.
ORCID-Profile: Caroline Coelho de Faria, Andrea Claudia Freitas Ferreira, Pedro Henrique Monteiro Torres, Rodrigo Soares Fortunato
Förderung
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
- National Council for Scientific and Technological Development
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
Zitieren
APA
de Vasconcelos E Souza, A., de Faria, C. C., Pereira, L. M., Ferreira, A. C. F., Torres, P. H. M., & Fortunato, R. S. (2024). Gene Expression and Prognostic Value of NADPH Oxidase Enzymes in Breast Cancer. International Journal of Molecular Sciences, 25(6), 3464. https://doi.org/10.3390/ijms25063464
Vancouver
de Vasconcelos E Souza A, de Faria CC, Pereira LM, Ferreira ACF, Torres PHM, Fortunato RS. Gene Expression and Prognostic Value of NADPH Oxidase Enzymes in Breast Cancer. International Journal of Molecular Sciences. 2024;25(6):3464. doi:10.3390/ijms25063464
BibTeX
@article{deVasconcelosESouza2024,
author = {de Vasconcelos E Souza, Andressa and de Faria, Caroline Coelho and Pereira, Leonardo Matta and Ferreira, Andrea Claudia Freitas and Torres, Pedro Henrique Monteiro and Fortunato, Rodrigo Soares},
title = {Gene Expression and Prognostic Value of NADPH Oxidase Enzymes in Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {6},
pages = {3464},
doi = {10.3390/ijms25063464}
}
EUVIMED